Work

Abstract PO036: Patients with recurrent epithelial endometrial cancers (EEC) and Wnt signaling alterations demonstrated greater clinical benefit when treated with DKN-01 monotherapy

Year: 2021

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.endomet20-po036

Authors: Rebecca Arend, Cesar Castro, Erica Hamilton, Kristopher LyBarger, Linda Duska, Michael Kagey, William Bradley, Jasgit Sachdev, Cynthia A. Sirard, David M. O'Malley

Institutions: University of Alabama at Birmingham, Massachusetts General Hospital, Sarah Cannon, Tennessee Oncology, HCA Midwest Division, University of Virginia Health System, Leap Therapeutics, Inc. (United States), Medical College of Wisconsin, HonorHealth, The Ohio State University

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3126191969

Cites:

Cited by: 2

Related to: 10